During the past decade, Specializirana bolnica za aktivno lechenie na hematologichni zabolyavania conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Specializirana bolnica za aktivno lechenie na hematologichni zabolyavania" #1 collaborator was "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Specializirana bolnica za aktivno lechenie na hematologichni zabolyavania" are "Disease, Hodgkin" (2 trials), "Lymphoma, Large-Cell, Anaplastic" (1 trials), "Lymphoma, Non-Hodgkin" (1 trials) and "Lymphoma, T-Cell, Cutaneous" (1 trials). Many other conditions were trialed in "Specializirana bolnica za aktivno lechenie na hematologichni zabolyavania" in a lesser frequency.

Most popular intervention types in "Specializirana bolnica za aktivno lechenie na hematologichni zabolyavania" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "brentuximab vedotin" (2 trials) and "placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Specializirana bolnica za aktivno lechenie na hematologichni zabolyavania" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Specializirana bolnica za aktivno lechenie na hematologichni zabolyavania". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Specializirana bolnica za aktivno lechenie na hematologichni zabolyavania, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Specializirana bolnica za aktivno lechenie na hematologichni zabolyavania, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".